Graves' disease and hyperthyroidism: vizsgálatok itt: Dél-Korea

2 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Daegu, Goyang, Guri-si, Seoul

  Életkor

  18 év to 75 év

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00
• 2. fázisCsak meghívásos
  A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

  Where

  Daegu, Gyeonggi-do

  Életkor

  18 év and over

  People

  372 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07286006